Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 9/20 | 0.56 |
| ▸ | ACE | P12821 | 1/20 | 0.52 |
| ▸ | PPARG | P37231 | 1/20 | 0.48 |
| ▸ | PPARA | Q07869 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1158094 | 1.00 | KIF11 (0.56) | KIF11ACEPPARGPPARALMNA | |
| SCHEMBL919742 | 1.00 | KIF11 (0.56) | KIF11ACEPPARGPPARALMNA | |
| Hydrochloric Acid SCHEMBL27713539 | 0.98 | KIF11 (0.55) | KIF11ACEPPARGPPARALMNA | |
| Hydrochloric Acid SCHEMBL7323852 | 0.98 | KIF11 (0.55) | KIF11ACEPPARGPPARALMNA | |
| SCHEMBL5696373 | 0.87 | KIF11 (0.57) | KIF11ACEALDH1A1 | |
| SCHEMBL7319459 | 0.87 | IDO1 (0.47) | KIF11ACEPPARGPPARALMNA | |
| SCHEMBL11796402 | 0.87 | KIF11 (0.57) | KIF11ACEALDH1A1 | |
| SCHEMBL24434185 | 0.85 | SLC7A5 (0.61) | KIF11 | |
| Benzylcysteine SCHEMBL515922 | 0.84 | ALPI (0.58) | KIF11ACE | |
| Benzylcysteine SCHEMBL1109643 | 0.84 | ALPI (0.58) | KIF11ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250353814-A1 | NON-PEPTIDIC CELL-PENETRATING MOTIFS | OHIO STATE INNOVATION FOUNDATION (US) | 2025-11-20 | — | — | US | claimed |
| US-12404236-B2 | Non-peptidic cell-penetrating motifs | OHIO STATE INNOVATION FOUNDATION (US) | 2025-09-02 | — | — | US | claimed |
| US-12329799-B2 | Peptidyl inhibitors of calcineurin-NFAT interaction | OHIO STATE INNOVATION FOUNDATION (US) | 2025-06-17 | — | — | US | claimed |
| CN-116120936-B | Etching liquid medicine and preparation method and application thereof | 上海天承化学有限公司 | 2024-06-25 | — | — | CN | claimed |
| US-20240101509-A1 | NON-PEPTIDIC CELL-PENETRATING MOTIFS | OHIO STATE INNOVATION FOUNDATION | 2024-03-28 | — | — | US | claimed |
| CN-117567639-A | Polypeptide conjugates for intracellular delivery of binding peptides | 俄亥俄州国家创新基金会 | 2024-02-20 | — | — | CN | claimed |
| US-20240033318-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | OHIO STATE INNOVATION FOUNDATION | 2024-02-01 | — | — | US | claimed |
| US-11814341-B2 | Non-peptidic cell-penetrating motifs | OHIO STATE INNOVATION FOUNDATION (US) | 2023-11-14 | — | — | US | claimed |
| US-20230212235-A1 | LOOPED PROTEINS COMPRISING CELL PENETRATING PEPTIDES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-07-06 | — | — | US | claimed |
| CN-116120936-A | Etching liquid medicine and preparation method and application thereof | 上海天承化学有限公司 | 2023-05-16 | — | — | CN | claimed |
| EP-4085064-A1 | LOOPED PROTEINS COMPRISING CELL PENETRATING PEPTIDES | Ohio State Innovation Foundation (US) | 2022-11-09 | — | — | EP | claimed |
| CN-115135665-A | Cyclic proteins comprising cell penetrating peptides | 俄亥俄州国家创新基金会 | 2022-09-30 | — | — | CN | claimed |
| WO-2022109058-A1 | NUCLEASES COMPRISING CELL PENETRATING PEPTIDE SEQUENCES | ENTRADA THERAPEUTICS, INC. (US) | 2022-05-27 | — | — | WO | claimed |
| WO-2021138397-A1 | LOOPED PROTEINS COMPRISING CELL PENETRATING PEPTIDES | OHIO STATE INNOVATION FOUNDATION (US) | 2021-07-08 | — | — | WO | claimed |
| EP-3787671-A1 | NON-PEPTIDIC CELL-PENETRATING MOTIFS | Ohio State Innovation Foundation (US) | 2021-03-10 | — | — | EP | claimed |
| US-4960881-A | REACTING AMINO ACID WITH ALPHA-CHLORINATED CARBONATE IN SOLVENT IN PRESENCE OF ACID SCAVENGER | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1990-10-02 | — | — | US | claimed |
| US-3976781-A | SULFUR CONTAINING AMINES | L'OREAL (FR) | 1976-08-24 | — | — | US | claimed |
| US-20260125426-A1 | CYCLIC CELL-PENETRATING PEPTIDES AND USES THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2026-05-07 | — | — | US | disclosed |
| EP-0254032-A2 | Neutral metalloendopeptidase inhibitors in the treatment of hypertension | SCHERING CORPORATION (US) | 1988-01-27 | — | — | EP | disclosed |
| US-3975365-A | Inhibitory octapeptides angiotensin II | G. D. SEARLE & CO. (US) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12404236-B2 | Non-peptidic cell-penetrating motifs | TIMM50, TIMM10, PITRM1 | KIF11 3188/4885ACE 4841/4885PPARG 2558/4885 |
| US-20240101509-A1 | NON-PEPTIDIC CELL-PENETRATING MOTIFS | TIMM50, TIMM10, PITRM1 | KIF11 3188/4885ACE 4841/4885PPARG 2558/4885 |
| US-20250353814-A1 | NON-PEPTIDIC CELL-PENETRATING MOTIFS | TIMM50, TIMM10, PITRM1 | KIF11 3188/4885ACE 4841/4885PPARG 2558/4885 |
| US-20230212235-A1 | LOOPED PROTEINS COMPRISING CELL PENETRATING PEPTIDES | LNPEP, SPPL2B, CNBP | KIF11 3139/4885ACE 3693/4885PPARG 4682/4885 |
| US-20260125426-A1 | CYCLIC CELL-PENETRATING PEPTIDES AND USES THEREOF | SLC7A1, TAP1, SLC7A5 | KIF11 4673/4885ACE 3598/4885PPARG 4308/4885 |
| US-11814341-B2 | Non-peptidic cell-penetrating motifs | TIMM50, TIMM10, PITRM1 | KIF11 3188/4885ACE 4841/4885PPARG 2558/4885 |
| US-12329799-B2 | Peptidyl inhibitors of calcineurin-NFAT interaction | CHP1, NFATC1, PPP3R1 | KIF11 4622/4885ACE 2182/4885PPARG 4701/4885 |
| US-20240033318-A1 | PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION | CHP1, NFATC1, PPP3R1 | KIF11 4622/4885ACE 2182/4885PPARG 4701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.